ASX 200 (ASX:XJO) midday update: Ansell crushed, ResMed upgraded

The ASX 200 is having a mixed day…

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

At lunch on Monday, the S&P/ASX 200 Index (ASX: XJO) has fought back from early weakness and is trading broadly flat. The benchmark index is currently down 1.5 points to 6,986.6 points.

Here's what is happening on the ASX 200 today:

Man looks shocked as he works on laptop on top a skyscraper with stockmarket figures in graphic behind him.

Image source: Getty Images

Ansell shares crushed

The Ansell Limited (ASX: ANN) share price is crashing lower today after it downgraded its earnings guidance. The health and safety products company revealed that it expects its earnings per share to be between 125 US cents to 145 US cents in FY 2022. This is down materially from its previous guidance of 175 US cents to 195 US cents. Management blamed this on softening demand and COVID-related operational challenges.

Pilbara Minerals' mixed quarterly update

The Pilbara Minerals Ltd (ASX: PLS) share price is pushing higher today following the release of a mixed second quarter update. Although the lithium miner fell short of its downgraded production guidance, which was given as late in the quarter as 21 December, and hinted that a downgrade to its guidance could be coming, investors have been buying its shares. This appears to be due to its expectations for the already sky high lithium prices to keep rising in the third quarter.

ResMed rises on broker upgrade

The ResMed Inc (ASX: RMD) share price is pushing higher today in response to a bullish broker note out of Goldman Sachs. According to the note, the broker has upgraded the sleep treatment company's shares to a buy rating with a $35.80 price target. Goldman notes that near-term challenges have created a long-term opportunity for ResMed.

Best and worst ASX 200 performers

The best performer on the ASX 200 on Monday has been the Zip Co Ltd (ASX: Z1P) share price with a 7% gain on no news. The worst performer by some distance has been the Ansell share price with a 17% decline. This follows the release of its trading update and guidance downgrade.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns and has recommended ZIPCOLTD FPO. The Motley Fool Australia has recommended Ansell Ltd. and ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Share Market News

Testing again

Read more »

Share Market News

Aaron Test 2

Read more »

Share Market News

Aaron Test

Read more »

Share Market News

JP Test

Read more »

Share Market News

JP Test

Read more »

Portrait of Discovery Fund portfolio managers Mark Devcich and Chris Bainbridge
Share Market News

Test

Portfolio managers Mark Devcich (left) and Chris Bainbridge. Image source: Discovery Fund test test

Read more »

a man in a hoodie grins slyly as he sits with his hands poised on a keyboard. He is superimposed with a graphic image of a computer screen asking for a password, suggesting he is a hacker.
Share Market News

Another ASX 200 company has been hit with a cyber incident. Here's what we know

Hackers have breached the systems of this ASX 200 company.

Read more »

a woman
Broker Notes

5 ASX 200 shares that inflation can't touch: expert

Regardless of whether you're a bull or a bear, cost pressures are a factor when buying stocks at the moment.

Read more »